1. Home
  2. RSKD vs SGP Comparison

RSKD vs SGP Comparison

Compare RSKD & SGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Riskified Ltd.

RSKD

Riskified Ltd.

N/A

Current Price

$6.59

Market Cap

671.7M

Sector

Technology

ML Signal

N/A

SGP

SpyGlass Pharma Inc. Common Stock

N/A

Current Price

$26.41

Market Cap

650.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RSKD
SGP
Founded
2012
2019
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
671.7M
650.9M
IPO Year
2021
2026

Fundamental Metrics

Financial Performance
Metric
RSKD
SGP
Price
$6.59
$26.41
Analyst Decision
Buy
Strong Buy
Analyst Count
7
5
Target Price
$5.96
$45.00
AVG Volume (30 Days)
934.5K
73.2K
Earning Date
05-13-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$12.09
N/A
Revenue Next Year
$10.08
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.70
$17.06
52 Week High
$6.48
$30.56

Technical Indicators

Market Signals
Indicator
RSKD
SGP
Relative Strength Index (RSI) 81.33 72.54
Support Level $4.41 $25.25
Resistance Level N/A $27.23
Average True Range (ATR) 0.25 1.36
MACD 0.14 0.28
Stochastic Oscillator 95.55 100.00

Price Performance

Historical Comparison
RSKD
SGP

About RSKD Riskified Ltd.

Riskified Ltd offers an AI-powered e-commerce risk intelligence platform that identifies the individual behind each online interaction for legitimacy, helping merchants (its customers) eliminate risk and uncertainty from their business. The company's core product, the Chargeback Guarantee, automatically approves or declines online orders with performance levels that vary in accordance with its merchants' priorities. Additionally, it offers other products that mitigate similar e-commerce risks for those same merchants, including Policy Protect, Dispute Resolve, and Account Secure. Geographically, Riskified generates maximum revenue from the United States, and the rest from other regions of the Americas, Europe, the Middle East and Africa (EMEA), and the Asia-Pacific (APAC) region.

About SGP SpyGlass Pharma Inc. Common Stock

SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.

Share on Social Networks: